high-intensity interval training 
 patient glaucoma 
 hit-glaucoma protocol 
 multicenter randomize 
 control exercise trial 
 Jan Van eijgen1,2† valentin schuhmann3† 
 emma-liina fingerroos3 Marie renier4 holger burchert3 
 Julia Maria kröpﬂ3 Amaryllis Van craenenbroeck5,6 
 Véronique cornelissen4 konstantin Gugleta7 
 Ingeborg stalmans1,2‡ Henner Hanssen3*‡ 
 1department Ophthalmology University Hospitals UZ Leuven Leuven Belgium 2research Group 
 Ophthalmology Department Neurosciences Leuven Belgium 3department Sports Exercise 
 Health Medical Faculty University Basel Basel Switzerland 4research Group Rehabilitation 
 Internal Disorders Department Rehabilitation Sciences Faculty Movement Rehabilitation 
 Sciences Leuven Belgium 5division Nephrology University Hospitals UZ Leuven Leuven Belgium 
 6nephrology Renal Transplantation Research Group Department Microbiology Immunology 
 transplantation Leuven Belgium 7department Ophthalmology University Basel Basel 
 Switzerland 
 Background Glaucoma stand prominent global cause irreversible 
 blindness primary treatment approach involve reduce intraocular 
 pressure 
 iop 
 
 
 one-third 
 
 patient 
 exhibit 
 disease 
 progression 
 despite 
 effective 
 iop 
 reduction 
 Microvascular 
 endothelial 
 function chronic inﬂammation oxidative stress know affect 
 retinal neuronal network associate disease severity 
 progression exercise training potential counteract mechanism 
 add-on treatment usual care 
 aim hit-glaucoma study investigate effect 6-month high- 
 intensity interval training hiit intermediate endpoint local retinal 
 microvascular systemic large artery function inﬂammation oxidative 
 stress clinical endpoint visual ﬁeld index optic nerve rim 
 assessment retinal nerve ﬁber layer thickness iop number eye drop vision- 
 related quality life ocular surface disease symptomatology 
 method study multi-center randomized control clinical trial 
 patient normal tension high-tension primary open angle 
 glaucoma study center 128 patient enrol 
 randomize 1:1 basis exercise intervention group usual 
 care control group primary microvascular endpoint retinal arteriolar 
 venular ﬂicker light-induced dilation 6 month primary endpoint 
 systemic circulation brachial artery ﬂow-mediated dilation 6 month 
 anticipated result hypothesize exercise therapy improve retinal 
 microvascular function ocular blood ﬂow patient glaucoma 
 open access 
 edited 
 Luodan Yang 
 South China Normal University China 
 REVIEWED 
 Elisa Grazioli 
 Foro Italico University Rome Italy 
 Eduardo Farias Sanches 
 Université de Genève Switzerland 
 Tobia Zanotto 
 University Kansas Medical Center 
 United States 
 correspondence 
 Emma-Liina Fingerroos 
 emmaliina.ﬁngerroos@unibas.ch 
 Henner Hanssen 
 henner.hanssen@unibas.ch 
 †these author contribute equally 
 work share ﬁrst authorship 
 ‡these author contribute equally 
 work share authorship 
 RECEIVED 04 December 2023 
 accepted 04 April 2024 
 published 16 2024 
 CITATION 
 Van Eijgen J Schuhmann V Fingerroos E-L 
 Renier M Burchert H kröpﬂjm 
 Van Craenenbroeck Cornelissen V Gugleta K 
 Stalmans Hanssen h 2024 high- 
 intensity interval training patient 
 glaucoma hit-glaucoma protocol 
 multicenter randomize control 
 exercise trial 
 physiol 15:1349313 
 doi 10.3389/fphys.2024.1349313 
 copyright 
 © 2024 Van Eijgen Schuhmann Fingerroos 
 Renier Burchert Kröpﬂ Van Craenenbroeck 
 Cornelissen Gugleta Stalmans Hanssen 
 open-access article distribute 
 term Creative Commons Attribution 
 License cc use distribution 
 reproduction forum permit 
 provide original author(s 
 copyright owner(s credit 
 original publication journal cite 
 accordance accept academic practice 
 use distribution reproduction 
 permit comply 
 term 
 Frontiers Physiology 
 frontiersin.org 
 01 
 type Study Protocol 
 published 16 2024 
 DOI 10.3389/fphys.2024.1349313 
 clinical outcome investigate effect exercise visual ﬁeld index 
 optic nerve rim assessment retinal nerve ﬁber layer thickness iop number eye 
 drop vision-related quality life ocular surface disease symptomatology 
 discussion hit-glaucoma blueprint trial design study effect 
 exercise training neurodegenerative cardiovascular disease importantly 
 patient expect beneﬁt improvement general health 
 cardiovascular co-morbiditie prove effective exercise offer new add-on 
 treatment strategy slow glaucoma progression 
 Clinical Trial Registration Number trial register Clinicaltrials.gov 
 identiﬁer nct06058598 currently recruitment stage 
 keywords 
 glaucoma 
 retinal 
 microcirculation 
 exercise 
 high 
 intensity 
 interval 
 training 
 cardiovascular risk intraocular pressure 
 Introduction 
 Glaucoma cardiovascular risk 
 Glaucoma optic neuropathy characterize degeneration 
 retinal ganglion cell thinning retinal nerve ﬁber layer 
 cupping optic disc Jonas et al. 2017 primary open angle 
 glaucoma poag sub-classiﬁed accord maximal 
 intraocular pressure iop arbitrary classiﬁcation cut- 
 21 mmhg iop stratiﬁes poag patient high-tension 
 glaucoma htg normal tension glaucoma ntg BMJ 
 Publishing Group Ltd 2021 hypothesize impaired 
 ocular perfusion pressure impaired microvascular endothelial 
 function increase oxidative stress additional disease 
 driver chu-tan et al. 2022 benoist d azy et al. 2016 
 Melgarejo et al. 2023 glaucomatous change lead loss 
 visual ﬁeld Venkataraman et al. 2010 Quigley 2011 
 15%–20 glaucoma case disease progress 
 blindness Susanna et al. 2015 glaucoma global 
 leading cause irreversible blindness Topouzis et al. 2007 
 affect 80 million people worldwide Topouzis et al. 2007 
 prevalence estimate increase 111 million 2040 
 accordance population ageing Tham et al. 2014 main goal 
 glaucoma treatment low iop one-third 
 patient disease progression despite iop lower Peters 
 et al. 2014 Susanna et al. 2015 
 subclinical pathophysiological feature cardiovascular 
 disease cvd overlap glaucoma suggest association 
 cvd glaucoma Choi et al. 2023 grow body 
 evidence indicate glaucoma associate systemic 
 cv risk factor obesity hypertension active smoking status 
 low high-density-lipoprotein hdl high low-density-lipoprotein 
 ldl level hypertriglyceridemia Lin et al. 2010 Kreft et al. 
 2019 Talaat et al. 2021 Wändell et al. 2022 primary 
 secondary 
 vascular 
 dysregulation 
 
 previously 
 
 hypothesize 
 
 component 
 
 
 etiology 
 
 glaucoma 
 Flammer Konieczka 2017 early research demonstrate 
 systemic comorbiditie associate endothelial lesion 
 atherosclerosis hypoperfusion lead damage 
 retinal nerve ﬁber layer underlying connective tissue 
 Dascalu 
 et 
 al. 
 2021 
 
 study 
 
 show 
 
 hypertension nocturnal hypotension daytime blood pressure 
 variability common cv risk factor progression Dascalu 
 et al. 2021 Van Eijgen et al. 2023 glaucoma 
 consider independent risk predictor new-onset cvd 
 Choi et al. 2023 vice versa conversely glaucoma patient 
 healthy lifestyle behavior show reduce risk 
 incident cvd compare unhealthy behavior Choi 
 et al. 2023 importance vascular non-iop 
 related risk factor underscore need screening alternative 
 biomarker glaucoma extension cv comorbiditie 
 date research association glaucoma disease 
 large artery structure function systemic circulation 
 scarce patient glaucoma suffer cv co-morbiditie 
 present systemic inﬂammation oxidative stress 
 prone develop large artery endothelial dysfunction 
 unfavorable arterial stiffness holistic approach include 
 assessment brachial artery ﬂow-mediated dilation fmd 
 pulse wave velocity pwv large artery surrogate 
 marker cv risk Vlachopoulos et al. 2010 Thijssen et al. 
 2011 provide thorough understanding 
 bidirectional relation systemic vascular disease local 
 neurodegenerative eye disease 
 Glaucoma retinal microcirculation 
 blood ﬂow retina maintain constant perfusion 
 level intricate interplay neurovascular 
 coupling myogenic response ﬂow-mediated mechanism 
 metabolic process facilitate release vasoactive 
 substance endothelium retinal tissue Koller 
 Toth 2012 capillary endothelial cell 
 vascular smooth muscle cell responsible pressure- 
 dependent myogenic constriction bayliss-effect ﬂow- 
 dependent nitric oxide (no)-induced dilation mean 
 shear stress Hanssen et al. 2022 addition endothelin-1 
 et-1 suggest play important role 
 maintenance regulation local blood ﬂow Palmer et al. 
 1988 Moncada Higgs 1993 et-1 
 ensure balance vasoconstrictive vasodilatory 
 capacity endothelium Koller Toth 2012 
 Frontiers Physiology 
 frontiersin.org 
 02 
 Van Eijgen et al. 
 10.3389/fphys.2024.1349313 
 local oxidative stress acknowledge factor 
 poag pathogenesis 30 year study 
 support role free radical-induced oxidative stress 
 trabecular meshwork tm cell loss zhou et al. 1999 retina 
 consistently expose reactive oxygen specie ros nita 
 Grzybowski 2016 imbalance ros production 
 antioxidant defense lead cellular damage apoptosis 
 Chrysostomou et al. 2013 pinazo-durán et al. 2015 elevated 
 iop visual ﬁeld damage link oxidative dna 
 damage affect tm cell saccà et al. 2005 Nita Grzybowski 
 2016 addition neurotrophic factor ntf particular brain- 
 derive neurotrophic factor bdnf identiﬁed 
 pathogenesis glaucoma Lambuk et al. 2022 bdnf locally 
 regulate retina transport brain retina 
 retrograde transport Lambuk et al. 2022 disruption 
 retrograde transport reduce level bdnf serum 
 
 ocular 
 ﬂuid 
 
 patient 
 
 glaucoma 
 suggest 
 
 neurotrophic 
 deprivation 
 contribute 
 
 glaucomatous 
 optic 
 neuropathy Lambuk et al. 2022 
 retinal microvascular endothelial dysfunction key predictive 
 vascular parameter arterial blood pressure vascular 
 rarefaction gugleta et al. 2012 Wang et al. 2015 Kwon et al. 
 2017 association retinal vessel diameter function cv 
 risk disease previously extensively review Hanssen 
 et al. 2022 narrowing central retinal arteriolar diameter 
 equivalent crae widening central retinal venular diameter 
 equivalent crve lowering arteriolar-to-venular diameter 
 ratio avr associate increase risk cvd cv 
 mortality Green Smith 2018 Vera et al. 2019 similar 
 retinal vessel diameter constellation find poag patient 
 compare healthy subject Chiquet et al. 2020 
 impaired retinal ﬂicker-induced dilation fid correlate 
 increase 
 cv 
 risk 
 
 diabete 
 Valenzuela 
 et 
 al. 
 2023 
 hyperglycemia Green Smith 2018 hypertension Vera 
 et al. 2019 dyslipidemia Karakucuk et al. 2020 obesity 
 Kaminsky et al. 2013 coronary artery disease ramos et al. 
 2015 chronic kidney disease whyte et al. 2013 blood 
 ﬂow alteration optic nerve head onh 
 identiﬁed signiﬁcant risk development progression 
 glaucoma highlight importance vascular system 
 responsiveness metabolic change disease progression 
 Flammer et al. 2002 
 exercise treatment patient 
 glaucoma 
 regular physical activity exercise potentially reduce 
 main underlie mechanism 
 development 
 progression cvd inﬂammation oxidative stress 
 endothelial dysfunction Green et al. 2017 Valenzuela et al. 2023 
 effect exercise training mediate repeat 
 hemodynamic stimulation occur bout exercise 
 stimulation lead increase production 
 bioavailability endothelium-derived substance 
 regular bout exercise induce functional structural 
 vascular adaptation improve systemic local blood ﬂow 
 oxygen supply Green Smith 2018 additionally 
 HIIT temporarily reduce iop value physically active young 
 subject Vera et al. 2019 Karakucuk et al. 2020 
 Cardiorespiratory ﬁtness inversely correlate cv mortality 
 morbidity Kaminsky et al. 2013 high-intensity interval 
 training hiit appear promising candidate 
 increase ﬁtness vascular health Wisløff et al. 2009 Whyte 
 et al. 2013 ramos et al. 2015 furthermore emerge evidence 
 indicate hiit effectively reduce oxidative stress increase 
 bioavailability area et al. 2019 compare 
 low-to-moderate intensity exercise interval high 
 intensity show superior improve insulin 
 sensitivity glucose metabolism hdl ldl leave ventricular 
 dysfunction bioavailability endothelial function 
 cardiorespiratory ﬁtness Tjønna et al. 2008 Wisløff et al. 2009 
 Whyte et al. 2013 Weston et al. 2014 ramos et al. 2015 streese 
 et al. 2018 substantial evidence suggest local 
 systemic vascular abnormality play important role 
 pathophysiology glaucoma Bonomi et al. 2000 Dascalu et al. 
 2021 glaucoma patient dynamic exercise jogging 
 cycling show low iop long intense 
 training have great effect streese et al. 2018 exercise 
 demonstrate induce high level bdnf improve 
 mitochondrial function zhu et al. 2018 chu-tan et al. 2022 
 notably have patient glaucoma adopt active lifestyle 
 beneﬁciary general health concomitant management 
 cv risk factor effective mean improve cv health 
 quality life 
 method analysis 
 long-term clinical goal hit-glaucoma slow 
 glaucoma progression exercise intervention trial 
 investigate effect hiit retinal microvascular structure 
 function systemic large artery health systemic 
 inﬂammation oxidative stress patient glaucoma 
 mechanism represent intermediate endpoint 
 know inﬂuence glaucoma progression 
 objective outcome measure 
 primary 
 retinal microvasculature local primary objective 
 retinal microcirculation examine effect 6- 
 month hiit-intervention maximal ﬂicker light-induced 
 retinal arteriolar afid venular vfid dilation 
 marker microvascular endothelial function patient 
 glaucoma hypothesize exercise treatment 
 signiﬁcantly 
 increase 
 retinal 
 afid 
 
 vfid 
 
 compare control group 
 large 
 artery 
 systemic 
 
 primary 
 objective 
 
 
 macrocirculation examine effect 6-month hiit- 
 intervention fmd marker large artery endothelial 
 function patient glaucoma hypothesize exercise 
 treatment signiﬁcantly increase 
 fmd 
 compare 
 
 control group 
 Frontiers Physiology 
 frontiersin.org 
 03 
 Van Eijgen et al. 
 10.3389/fphys.2024.1349313 
 secondary 
 investigate 6 month exercise training improve 
 CRAE crve diameter glaucoma patient compare 
 control group 
 investigate 6 month exercise training improve 
 PWV marker large artery stiffness glaucoma patient 
 compare control group 
 investigate retinal afid vfid ﬂicker light 
 derive marker retinal crae crve 
 6 month exercise training 6 month self- 
 maintenance exercise training compare control 
 group 12 month 
 investigate large artery fmd pwv 6 month 
 exercise training 6 month self-maintenance 
 exercise training compare control group 12 month 
 investigate 6 month exercise training increase 
 brain-derived neurotrophic factor bdnf level reduce 
 inﬂammation oxidative stress peripheral blood 
 assess iop use iop lower eye drop occurrence laser 
 trabeculoplasty surgical intervention 12 month 
 intervention group compare control group 
 assess Optical Coherence Tomography oct visual 
 ﬁeld metric 12 month intervention group 
 compare control group 
 assess peak aerobic capacity vo2peak objectively 
 measure physical activity 12 month 
 intervention group compare control group 
 compare change 24 h ambulatory blood pressure 
 measurement blood pressure variability 
 12 month intervention group control group 
 compare change vision-related quality life 
 12 month intervention group control group 
 compare change questionnaire-derived ocular surface 
 disease 
 index 
 
 dry 
 eye 
 disease 
 symptom 
 
 
 intervention group control group 
 study design 
 hit-glaucoma study multi-center prospective 
 randomize control clinical intervention study center 
 involve University Basel Switzerland comprise 
 Department Sport Exercise Health dsbg 
 Department Ophthalmology University Leuven KU 
 Leuven belgium comprise Department Ophthalmology 
 Department Neurosciences Department Rehabilitation 
 Sciences Basel clinical ophthalmological examination 
 carry glaucoma consultation University Eye 
 Clinic retinal vessel analysis systemic vascular diagnostic 
 analysis include cardiopulmonary exercise testing CPET 
 exercise training perform DSBG Leuven clinical 
 ophthalmological assessment retinal vessel analysis 
 analysis perform glaucoma consultation 
 University Eye Clinic UZ Leuven belgium systemic vascular 
 diagnostic CPET exercise training perform 
 Department Rehabilitation Sciences 
 hit-glaucoma study effect 6-month 
 exercise intervention patient glaucoma n = 64 
 compare control group glaucoma patient n = 64 
 receive 
 guideline-based 
 physical 
 activity 
 recommendation 
 150–300 min moderate-intensity aerobic physical activity 
 75–150 min 
 
 vigorous-intensity 
 activity 
 
 equivalent 
 combination week account 
 concomitant change glaucoma standard-of-care medication 
 patient ntg htg randomize 
 group figure 1 intervention group hiit n = 32 
 center combined progressive moderate 
 continuous training mct hiit control group cg 
 n = 32 center receive physical activity recommendation 
 control condition exercise training offer adjunct 
 treatment standard care supervised exercise 
 intervention terminate 6 month follow 6 month 
 
 unsupervised 
 self-maintenance 
 exercise 
 training 
 
 control condition 
 figure 1 
 Trial ﬂow chart 
 Frontiers Physiology 
 frontiersin.org 
 04 
 Van Eijgen et al. 
 10.3389/fphys.2024.1349313 
 selection subject 
 Inclusion criterion 
 patient eligible inclusion meet follow 
 criterion age 40–80 year diagnose poag ntg 
 htg regular follow-up study center 
 have sign write informed consent 
 exclusion criterion 
 patient eligible study meet follow 
 criterion have glaucoma surgery 6 month start 
 project change topical medication laser trabeculoplasty 
 3 month start project severe glaucoma visual 
 ﬁeld mean deviation low −12db eye disease 
 signiﬁcant impact visual ﬁeld life-threatening arrhythmia 
 FIGURE 2 
 overview training session exercise intervention control group 
 table 1 exercise intervention 
 phase 1 
 Week 1–6 
 phase 2 
 Week 7–12 
 phase 3 
 Week 13–26 
 supervised session 
 Week 1–6 1x/week 
 Week 7–10 1x/week Week 11–12 1x/2 week 
 Week 13–26 1x/2 week 
 modality/week 
 3 x MCT 
 2 x MCT + 1 x hiit 
 1 x MCT + 2 x hiit 
 warm-up 
 5 min ramp 25 
 vo2reserve 
 5 min ramp 25 vo2reserve 
 5 min ramp 25 vo2reserve 
 duration condition 
 phase 
 Week 1 30 min 
 MCT 45 min hiit 30 min 6 × 2 min)+(6 × 3 min 
 MCT 45 min hiit 28 min 4 × 4 min)+(4 × 3 min 
 Week 2 35 min 
 Week 3 35 min 
 Week 4 35 min 
 Week 5 40 min 
 Week 6 45 min 
 Intensity condition 
 phase 
 Week 1–2 50 
 vo2reserve 
 Week 3–6 65 
 vo2reserve 
 MCT 
 MCT 
 65 vo2reserve 
 65 vo2reserve 
 hiit 
 hiit 
 6 × 2 min 
 4 × 4 min 
 1 min ramp 80 vo2reserve follow 1 min 
 sustaining 80 vo2reserve 
 1 min ramp 85 vo2reserve follow 3 min 
 sustaining 85 vo2reserve 
 Interspersed 6 × 3 min 
 Interspersed 4 × 3 min 
 50 vo2reserve 
 60 vo2reserve 
 Cool 
 5 min 
 5 min 
 5 min 
 Frontiers Physiology 
 frontiersin.org 
 05 
 Van Eijgen et al. 
 10.3389/fphys.2024.1349313 
 aberrant 
 CPET 
 e.g. 
 sign 
 
 ischemia 
 
 preclude 
 participation exercise trial insulin-treated diabete chronic 
 obstructive pulmonary disease cancer mental clinical physical 
 limitation precluding safe participation high intensity exercise 
 program subject perform 150 min moderate 
 vigorous physical activity week deﬁne Physical 
 Activity Vital Sign questionnaire exclude Kuntz et al. 
 2021 participant consider study participation 
 criterion document Screening Log include 
 screening failure 
 recruitment randomization 
 eligible glaucoma patient invite participate 
 routine glaucoma consultation Eye Clinic University 
 Hospital Basel Glaucoma Clinic University Hospitals 
 UZ Leuven overall 128 patient enrol 64 poag htg 
 ntg patient Basel 64 Leuven 
 participant randomize hiit cg stratiﬁed 
 study site randomization carry Redcap ® 
 ensure conceal allocation minimize selection bias block 
 randomization perform block 4–6 redcap ® 
 table 2 Examination overview visit 
 overview examination 
 t0 
 t1 
 t2 
 t3 
 t4 
 Glaucoma Standard Care 
 Visual Acuity 
 X 
 x 
 x 
 x 
 autorefraction/autokeratometry 
 x 
 x 
 x 
 X 
 Visual Field 
 X 
 x 
 x 
 X 
 Intraocular Pressure 
 X 
 x 
 x 
 X 
 Retinal Photography 
 X 
 x 
 x 
 x 
 Optical Coherence Tomography 
 x 
 x 
 x 
 X 
 Retinal Microvascular assessment 
 static Retinal Vessel Analysis 
 x 
 x 
 x 
 x 
 Dynamic Retinal Vessel Analysis 
 x 
 x 
 x 
 X 
 Laser Speckle Flowgraphy basel 
 x 
 x 
 x 
 x 
 Optical Coherence Tomography Angiography 
 X 
 x 
 x 
 X 
 large Artery Structure Function 
 Flow Mediated Dilation 
 x 
 x 
 x 
 X 
 pulse Wave Velocity 
 x 
 x 
 x 
 X 
 Physical activity fitness 
 Cardiopulmonary Exercise Testing vo2peak 
 x 
 x 
 x 
 X 
 Accelerometer 
 x 
 x 
 x 
 X 
 assessment 
 Anthropometry weight height bmi bp ecg 
 x 
 x 
 x 
 x 
 24 h ambulatory Blood Pressure Measurement 
 x 
 x 
 x 
 X 
 Blood Urine Sampling 
 X 
 x 
 x 
 X 
 Safety Monitoring 
 X 
 x 
 x 
 X 
 Questionnaires 
 International Physical Activity Questionnaire ipaq 
 x 
 x 
 x 
 X 
 National Eye Institute 25-item Visual Function Questionnaire nei vfq-25 
 x 
 x 
 x 
 X 
 Glaucoma Activity Limitation questionnaire gal-9 
 x 
 x 
 x 
 x 
 Ocular Surface Disease Index osdi 
 x 
 x 
 x 
 x 
 Five-item Dry Eye Questionnaire deq-5 
 x 
 x 
 x 
 x 
 t0 baseline t1 measurement 3 month t2 measurement 6 month t3 measurement 1 year t4 yearly 16 year bmi body mass index bp blood pressure ecg 
 electrocardiography safety monitor trial 
 Frontiers Physiology 
 frontiersin.org 
 06 
 Van Eijgen et al. 
 10.3389/fphys.2024.1349313 
 Patients receive unique identiﬁcation number 
 subsequent transcript collect datum 
 Redcap ® database instead participant´s assure 
 pseudonymity datum document web-based 
 platform follow randomization procedure 
 established single blinding study personnel involve 
 assessment study visit avoid motivational bias analysis 
 imaging datum perform off-line blind researcher 
 interventional method 
 Intervention group 
 patient randomize exercise intervention group 
 follow 6-month long progressive exercise training program 
 program consist 6 week MCT follow 20 week 
 MCT combine hiit 6-month period follow 
 maintenance 
 non-supervised 
 home-based 
 physical 
 activity 
 program Figure 2 ﬁrst 6 month patient 
 participate 18 supervised center-based exercise session 
 adjunct remotely monitor guide home-based exercise 
 intervention number supervised center-based session 
 gradually decrease time encourage self-management 
 empowerment ﬁrst second month patient 
 participate supervised training session week start 
 month sixth patient participate 
 supervised session second week 
 6-month exercise program consist phase aerobic 
 training perform time week cycle ergometer 
 phase 6-week run-in period acquaint patient 
 exercise therapy allow gradual progressive aerobic 
 conditioning phase session MCT 
 perform phase session MCT replace 
 hiit session phase patient execute 
 session hiit session MCT duration 
 intensity training session speciﬁed Table 1 
 Intensity training session guide heart rate 
 monitoring correspond speciﬁc percentage vo2 
 reserve vo2 reserve deﬁne vo2max vo2rest x 
 vo2rest Swain Leutholtz 1997 patient monitor 
 exercise intensity duration frequency mean commercial 
 wearable exercise tracker ask upload training 
 datum accompany platform addition self-reported 
 rate perceive exertion collect individualized training 
 log 6-month exercise intervention follow 
 maintenance physical activity program tailor patient 
 preference 60-min face-to-face consultation 
 6 month exercise supervise support 
 study team 
 control group 
 cg verbally receive exercise recommendation 
 line current guideline pelliccia et al. 2020 
 FIGURE 3 
 visual representation study concept effect exercise training glaucoma progression cardiovascular risk local systemic 
 disease mechanism 
 Frontiers Physiology 
 frontiersin.org 
 07 
 Van Eijgen et al. 
 10.3389/fphys.2024.1349313 
 recommend physical activity 150 min week 
 moderate high intensity counselling guidance 
 objective measure physical activity mean wearable 
 provide 
 concomitant care 
 intervention control group continue receive 
 routine medical pharmacological management 
 assessment 
 overview method apply timetable 
 schedule visit give table 2 follow section offer 
 summary diagnostic method 
 clinical ophthalmological assessment 
 Visual ﬁeld examination Visual Field quantiﬁcation gold 
 standard assessment visual performance glaucoma patient 
 quintessential glaucoma diagnosis follow-up 
 Humphrey visual ﬁeld Carl Zeiss Meditec Inc. Dublin 
 Octopus visual ﬁeld Haag-Streit AG Koeniz Switzerland 
 examination 
 optical coherence tomography oct oct make use 
 interferometry visible wavelength spectrum 
 orthogonal slice retina high resolution scanning 
 macular retinal thickness ganglion cell layer retinal nerve ﬁber 
 layer thickness optic nerve rim assessment perform 
 Heidelberg Spectralis Heidelberg Engineering Inc. Franklin 
 United States particular macular oct cube radial 
 circumpapillary scan ONH take 
 optical coherence tomography angiography octa octa 
 imaging well compare subtraction angiography 
 subtract oct image mobile 
 move blood column result three-dimensional 
 reconstruction retinal vascular tree level small 
 capillary 10 ° 20 ° vascular scan macula 15 ° scan 
 optic nerve capture Heidelberg Spectralis 
 Heidelberg Engineering Inc. Franklin United States 
 visual acuity testing visual acuity measure 
 center-speciﬁc calibrate visual acuity chart express 
 universal Logarithm Minimum Angle Resolution 
 logmar scoring 
 autorefraction/autokeratometry 
 
 refraction 
 sphere 
 cylinder 
 
 axis 
 
 
 measure 
 
 
 automate 
 keratorefractometer optical quality refraction eye 
 important visual acuity testing optical adjustment 
 imaging 
 intraocular pressure iop iop measure use 
 Goldmann Applanation Tonometry prior pupil dilation 
 retinal microvascular assessment 
 dynamic retinal vessel analysis afid vfid assess 
 biomarker endothelial function retinal microcirculation 
 
 dilation 
 
 response 
 
 ﬂicker 
 light 
 
 facilitated 
 
 neurovascular coupling dilation capacity percent change 
 baseline diameter assess Dynamic Vessel 
 Analyzer 3.0 dva IMEDOS Systems Jena Germany Hanssen 
 et al. 2022 device consist retinal camera imedo 
 Systems Jena Germany charge-coupled device camera 
 electronic online imaging personal computer system 
 control analysis recording obtain datum cycle 
 ﬂicker provocation apply 80 s recovery 
 cycle extract a.o mean value afid vfid streese 
 et al. 2021 
 static retinal vessel analysis take fundus image retina 
 allow assessment crae crve diameter 
 avr parameter show reﬂect systemic cv risk 
 
 analyze 
 
 
 healthy 
 eye 
 
 represent 
 retinal 
 microvascular health Hanssen et al. 2022 retinal vessel image 
 take static Retinal Vessel Analyzer sva-t 
 Imedos 
 Systems 
 UG 
 Jena 
 Germany 
 
 sva-t 
 system 
 consist fundus camera topcon trc nw8 
 analyzing software Visualis 2.80 imedo System ug 
 image take retina affect eye retinal 
 vessel diameter identiﬁed analyze use semi- 
 automated software vesselmap 2 Visualis Imedos Systems UG 
 automate software lunet pvbm Fhima et al. 2023 
 laser speckle ﬂowgraphy lsfg ocular perfusion 
 measure laser ﬂowgraphy mean blur rate mbr estimate 
 ﬂow lsfg Nidek Inc. United States basel site 
 device use low-power semi-conductor laser wavelength 
 830 nm laser class 1 measurement light lsfg measure real- 
 time fundus blood ﬂow relative blood ﬂow express 
 arbitrary unit mbr total 118 frame record 4 s. 
 Mean perfusion ONH analyze LSFG Analyzer 
 software version 1.0.0.0 
 Macrovascular assessment 
 flow-mediated dilation fmd gold standard method 
 non-invasive evaluation endothelial function large artery 
 ultrasound-based device 2d imaging dilation 
 brachial artery measure 3 minute 5 minute cuff- 
 induced blood ﬂow restriction UNEX Sakae Nakaku Nagoya 
 Japan diameter brachial artery measure rest 
 rest diameter shortly cuff deﬂation base diameter 
 3 minute increase blood ﬂow max diameter analyze 
 ﬂow endothelium-dependent vasodilation blunt fmd 
 link high cv event risk show 
 prognostic value development cvd ras et al. 2013 
 pulse-wave velocity analysis carotid-femoral pulse wave 
 velocity estimate central aortic blood pressure 
 measure 
 
 
 sphygmocor 
 xcel 
 Atcor 
 Medical 
 184 Shuman Blvd Naperville United States pwv gold 
 standard measurement arterial stiffness chalmer et al. 
 2010 good intra- interobserver reproducibility technique 
 demonstrate healthy population patient 
 elevated cv risk streese et al. 2020b 10 minute rest pulse 
 wave record high-ﬁdelity tonometric transducer 
 carotid site simultaneous recording pulse wave cuff- 
 base oscillometric detection upper leg pulse wave distance 
 determine use direct method recommend previous 
 consensus document Van Bortel et al. 2012 distance 
 carotid artery cuff measure follow distance 
 Frontiers Physiology 
 frontiersin.org 
 08 
 Van Eijgen et al. 
 10.3389/fphys.2024.1349313 
 femoral artery cuff distance 
 carotid femoral palpation site calculate subtraction 
 measurement meet quality control parameter consecutive 
 measurement visually acceptable 0.5 m/s 
 standard deviation < 10 mean valid measurement 
 represent pwv value 
 exercise capacity testing 
 Cardiopulmonary exercise testing CPET exercise capacity 
 assess CPET measure peak exercise oxygen consumption 
 vo2peak cpet perform electromagnetically brake 
 cycle ergometer ergoline 900 Bitz Germany accord 
 standard American Thoracic Society/American College 
 Chest Physicians statement cardiopulmonary exercise testing 
 American Thoracic SocietyAmerican College Chest Physicians 
 2003 
 Individualized 
 ramp 
 protocol 
 
 
 perform 
 
 volitional 
 exhaustion 
 
 appearance 
 
 clinically 
 signiﬁcant 
 symptom heart rate continuously monitor 12-lead 
 ecg respiratory datum continuously measure breath-by- 
 breath 
 analysis 
 oxycon 
 Pro 
 Jaeger 
 CareFusion 
 Germany 
 | 
 JAEGER Vyntus CPX Vyaire medical United States vo2peak 
 deﬁne high 30-s average vo2 end test 
 blood urine sampling 
 Blood draw fast state venipuncture cubital 
 fossa routine analysis circulate biomarker 
 systemic cv risk 1 day rest physical exercise 
 1 week perform baseline 3 month 
 6 month 12 month trial inclusion urine collect 
 fasten state routine urine analysis determination 
 microalbuminuria routine blood analysis encompass 
 Hemogram differential blood cell count 
 Biochemistry high-sensitive c-reactive protein hscrp 
 glucose hdl ldl trigliceride hba1c kidney marker 
 creatinine sodium potassium 
 biomarker endothelial function premature vascular 
 ageing 
 comprise 
 different 
 cellular 
 circulate 
 mature 
 endothelial endothelial progenitor cell assess 
 Basel protein marker transcriptomic 
 genomic epigenetic marker 
 elisa kit accord manufacturer 
 instruction determination interleukine-6 bender 
 Med-Systems Austria tumor necrosis factor-α Biosource 
 United States 3-nitrotyrosine oxidative stress Cell Biolabs 
 United States bdnf biosensis United States 
 high-sensitive c-reactive protein hs-crp analyse 
 immunoturbidimetric latex crp assay Cobas 8000 roche- 
 Diagnostics Basel 
 blood sample centrifuge supernatant aliquot 
 frozen −80 ° c batch analysis 
 Questionnaires 
 International Physical Activity Questionnaire ipaq short 
 form ipaq validate german dutch 
 version apply identify quantity kind daily 
 physical activity participant questionnaire 
 metabolic equivalent met 1 hour met/h calculate 
 week instrument demonstrate good reliability 
 validity Craig et al. 2003 
 National Eye Institute 25-item Visual Function Questionnaire 
 nei vfq-25 nei vfq-25 assess vision related quality life 
 vision comfort daily activity driving newspaper reading 
 cinema mangione et al. 2001 
 Glaucoma Activity Limitation Questionnaire gal-9 gal-9 
 shorten version Glaucoma Quality life-15 
 assess vision related quality life speciﬁcally develop 
 glaucoma patient Nayyar et al. 2022 
 Ocular Surface Disease Index osdi OSDI assess effect 
 dry eye disease vision-related function Guarnieri et al. 2020 
 five-item Dry Eye Questionnaire deq-5 deq-5 
 discriminate self-assessed severity dry eye disease chalmer 
 et al. 2010 
 assessment 
 Daily physical activity physical activity baseline 
 6 month 12 month follow-up measure 
 objectively validate research-based accelerometer 
 geneactiv ActiGraph ™ gt3x ActiGraph llc Pensacola 
 Florida United States wear 8 consecutive day 
 order obtain number step energy expenditure met rate 
 physical activity intensity sedentary bout activity count 
 activity bout 
 24 h ambulatory blood pressure measurement patient 
 receive 
 
 validate 
 oscillometric 
 
 90202 
 
 90207 SpaceLabs monitor SpaceLabs Inc. Redmond wa 
 abpmpro Research 
 model 
 somnomedic 
 gmbh 
 Randersacker ger program obtain 
 ambulatory blood pressure reading interval 15 20 min 
 day 06:00 00:00 30-min interval 
 night 00:00 06:00 
 Anthropometry Patient height weight body mass index 
 bmi rest electrocardiogram ecg blood pressure bp 
 measure standardized procedure body fat 
 measure bioelectrical impedance analysis InBody Biospace 
 California United States 
 data analysis 
 primary outcome study effect 6-month exercise 
 training maximal afid vfid hiit group compare 
 control group descriptive statistic mean standard deviation 
 describe baseline follow-up characteristic 
 normal distribution datum test mean shapiro- 
 Wilk test analyze intervention effect 6 month use 
 analysis covariance ancova accord intention-to- 
 treat principle compare difference primary secondary 
 endpoint hiit control group correct 
 corresponding baseline value main confounder boxplot 
 visualize primary secondary endpoint 
 6-month exercise intervention fraction 
 missing value exceed 5 account miss datum 
 Frontiers Physiology 
 frontiersin.org 
 09 
 Van Eijgen et al. 
 10.3389/fphys.2024.1349313 
 multiple imputation multiple linear regression model 
 adjust covariable age sex describe 
 association delta change retinal microvascular 
 adaptation delta change classical risk factor 
 vo2peak bmi systolic diastolic bp fasting glucose serum 
 lipid hs-crp inﬂammatory oxidative stress marker 
 bdnf change glaucoma therapy coincide course 
 project trial interfere routine glaucoma 
 management particular need correct 
 therapy change statistical analysis change therapy 
 include separate variable step-up therapy 
 surgery laser trabeculoplasty additional drop 
 code binary summarize variable yes/no separate 
 variable quantify total number drop total number 
 surgery model assumption check graphically 
 residual diagnostic plot statistical test two-sided 
 signiﬁcant level set 0.05 
 Sample size calculation 
 retinal microcirculation sample size calculation 
 base regression coefﬁcient group indicator hiit 
 vs. cg ancova describe calculation 
 inform publish standard error coefﬁcient 
 comparable trial analysis speciﬁcally assume standard 
 error 0.23 maximal afid streese et al. 2020a 
 0.0051 avr streese et al. 2020b detect adjusted group 
 difference 0.51 maximal afid 0.03 avr 
 power 80 total sample size 112 20 require 
 respectively 
 envisage 112 complete 
 participation study 
 case meet sample size target 
 calculate minimum detectable β range sample size 
 case recruitment example 90 patient minimum 
 detectable β maximal afid 0.60 exercise- 
 induced dilation change power 0.8 minimum 
 detectable β avr range 0.014 exercise- 
 induced change ratio reﬂect achievable 
 clinically relevant improvement retinal microvascular health 
 put expect effect perspective normative datum 
 previously report exercise efﬁcacy 
 large artery function additional sample size calculation 
 perform base give sample size previous 
 power calculation retinal endpoint detectable group 
 difference calculation base assume correlation 
 coefﬁcient r = 0.6 pre- post-measurement 
 standard deviation 3 given total sample size n = 124 
 62 group mct/hiit group dropout rate 10 
 calculation inform publish standard deviation 
 coefﬁcient comparable trial analysis Lenth 
 2001 Moriguchi et al. 2005 Luk et al. 2012 ras et al. 2013 
 Heiss et al. 2023 n = 62 group assumption 
 r = 0.6 pre- post-measurement 80 power 
 detect group difference fmd 1.3 large 
 90 power detect group difference fmd 1.5 
 large target sample size 124 participant 
 study 
 correlation pre- post-measurement 
 reach r = 0.6 detect group difference fmd 1.6 
 80 power bad case reﬂect 
 achievable clinically meaningful improvement large artery 
 function put expect effect perspective recently 
 publish reference range serve target 
 tailor cardiovascular risk stratiﬁcation prevention luk et al. 
 2012 Heiss et al. 2023 
 Data management 
 Data management perform experienced datum 
 scientist compliance guideline good clinical 
 practice collaboration Clinical Trial Unit ctu 
 University Basel Clinical Trial Center ctc 
 University Hospitals UZ Leuven electronic case report 
 form ecrf redcap center personal 
 sensitive datum abide General Data Protection Regulation 
 2016/67 FDA Good Clinical Practice guideline different 
 datum source collect patient datum digitally record 
 form questionnaire clinical examination report 
 image ﬁle management include consistency check datum 
 input personal datum ﬁnding survey digitally 
 store encrypted format exclusively 
 study name initial complete birth date 
 identiﬁer 
 
 
 include 
 
 
 encrypted 
 code 
 pseudonomization datum acquisition complete 
 statistical analysis perform solely pseudonomize 
 datum set pseudonomized datum numeric database send 
 Leuven coordinating center non-disclosure party 
 restriction stipulate informed consent 
 form study datum ﬁle archive 
 dsbg KU Leuven server dedicate Research Group 
 Ophthalmology Data Management Plan approve 
 institutional research governance committee ethic review 
 authority 
 Discussion 
 hit-glaucoma aim establish exercise treatment 
 viable new adjunct therapy modality glaucoma result 
 study potential enforce paradigm shift treatment 
 patient glaucoma additionally apply exercise 
 treatment exercise treatment potential improve 
 microvascular endothelial function improve ocular perfusion 
 induce anti-inﬂammatory anti-oxidative capacity 
 Glaucoma potentially see sequel 
 systemic dysfunctional pathway theoretical microvascular 
 dysfunction exercise underused readily available 
 treatment strategy great potential add treatment 
 usual care 
 ﬁrst foremost clinical study elaborate 
 potential 
 exercise-induced 
 mechanism 
 
 treatment 
 effect 
 nonetheless study investigate local retinal 
 systemic pathophysiological molecular mechanism 
 involve exercise-induced amelioration disease 
 progression way comprehensive highly 
 innovative approach combine exercise preventive medicine 
 Frontiers Physiology 
 frontiersin.org 
 10 
 Van Eijgen et al. 
 10.3389/fphys.2024.1349313 
 
 
 retinal 
 microvascular 
 pathophysiology 
 
 clinical 
 ophthalmology potential set new standard offer 
 new option current treatment approach glaucoma 
 objective hit-glaucoma study primarily 
 investigate 
 intermediate 
 endpoint 
 
 
 local 
 retinal 
 microvascular 
 dysfunction 
 
 systemic 
 vascular 
 plasticity 
 inﬂammation oxidative stress key pathological 
 feature etiology glaucoma describe local 
 systemic mechanism impact disease progression aim 
 demonstrate efﬁcacy exercise add-on treatment 
 disease entity potential help stabilize disease 
 reduce glaucoma-associated cv risk aim concept 
 study summarize Figure 3 study investigate 
 effect exercise disease speciﬁc clinical endpoint visual 
 ﬁeld oct index iop use iop lower eye drop 
 necessity laser trabeculoplasty surgical intervention 
 vision related quality life symptomatology ocular surface 
 disease initial phase study short robust 
 reliable study glaucoma progression term visual ﬁeld 
 oct longer-term follow-up ensure assess change 
 long period ﬁrst patient schedule February 2024 
 conclusion comprehensive hit-glaucoma study 
 approach set ground new add-on exercise 
 treatment regime glaucoma represent blueprint 
 exercise 
 study 
 
 
 kind 
 
 (micro)vascular 
 disease 
 additionally mobilize patient beneﬁt associate cv 
 comorbiditie exercise prescription consider 
 effective polypill treatment systemic cv disease 
 likewise prove effective treatment strategy glaucoma 
 chronic smolder neurodegenerative disease 
 data availability statement 
 original contribution present study include 
 article/supplementary material inquiry direct 
 corresponding author 
 ethic statement 
 study approve Ethics Committee 
 Northwestern Central Switzerland eknz project-id 
 2023 01397 Ethics Committee Research UZ/KU 
 Leuven EC Research project-id s67593 study 
 carry accordance protocol principle 
 state Declaration Helsinki Guidelines Good 
 Clinical Practice gcp World Medical Association 2013 
 study protocol design accord SPIRIT Guidelines 
 respect use medical device study 
 conduct European Directive medical device 93/ 
 42/eec iso norm 14155 iso 14971 swiss Law 
 swiss regulatory authority requirement respective 
 ethic committee receive annual safety report 
 inform 
 
 study 
 stop/end 
 
 agreement 
 
 local 
 requirement participation study voluntary 
 potential participant inform study 
 procedure time sign informed consent 
 potential participant 24-hour 
 thinking period sign consent participant later 
 receive personal study id data acquisition perform 
 single-blinded study member study datum enter 
 ecrf authorized personnel 
 Author contribution 
 jv conceptualization Data curation funding acquisition 
 Methodology Project administration Supervision Visualization 
 writing original 
 draft 
 writing review 
 
 editing 
 vs 
 Investigation 
 Project 
 administration 
 Visualization 
 writing original 
 draft 
 writing review 
 
 editing 
 e-lf 
 Investigation 
 Project 
 administration 
 Visualization 
 writing original 
 draft 
 writing review 
 
 editing 
 mr 
 Investigation Methodology writing review editing hb 
 Data curation methodology writing review editing jk 
 Conceptualization 
 Methodology 
 Project 
 administration 
 writing review 
 
 editing 
 av 
 Conceptualization 
 Investigation 
 Methodology 
 Resources 
 Supervision 
 writing review 
 
 editing 
 vc 
 Conceptualization 
 Data 
 curation 
 Funding 
 acquisition 
 Investigation 
 Methodology 
 Project administration Resources Supervision writing review 
 
 editing 
 kg 
 Conceptualization 
 Funding 
 acquisition 
 Investigation 
 Methodology 
 Resources 
 Supervision 
 writing review 
 
 editing 
 
 Conceptualization 
 Funding 
 acquisition investigation Methodology Resources Supervision 
 writing review 
 
 editing 
 hh 
 Conceptualization 
 Data 
 curation 
 Funding 
 acquisition 
 Investigation 
 Methodology 
 Project administration Resources Supervision writing review 
 editing 
 Funding 
 author(s declare ﬁnancial support receive 
 research authorship and/or publication article study 
 fund Swiss National Science Foundation snf 32003bl 
 212656/1 
 
 
 Research 
 Foundation 
 Flanders 
 fwo g005023n 
 Conﬂict interest 
 author declare research conduct 
 absence commercial ﬁnancial relationship 
 construe potential conﬂict interest 
 Publisher note 
 claim express article solely author 
 
 
 
 necessarily 
 represent 
 
 
 
 afﬁliated 
 organization publisher editor 
 reviewer product evaluate article 
 claim manufacturer guarantee 
 endorse publisher 
 Frontiers Physiology 
 frontiersin.org 
 11 
 Van Eijgen et al. 
 10.3389/fphys.2024.1349313 
 References 
 American Thoracic SocietyAmerican College Chest Physicians 2003 ats/accp 
 Statement cardiopulmonary exercise testing J. Respir crit care Med 167 2 
 211–277 doi:10.1164/rccm.167.2.211 
 Areas G. P. T. Mazzuco a. Caruso F. R. Jaenisch R. B. Cabiddu R. Phillips S. a. 
 et al. 2019 flow-mediated dilation heart failure review implication 
 physical rehabilitation heart Fail Rev. 24 1 69–80 doi:10.1007/s10741 018 9719 7 
 Benoist d azy C. Pereira B. Chiambaretta F. Dutheil F. 2016 oxidative 
 anti-oxidative stress marker chronic glaucoma systematic review meta- 
 analysis plos 11 12 e0166915 doi:10.1371/journal.pone.0166915 
 BMJ Publishing Group Ltd 2021 european glaucoma society terminology 
 guideline 
 
 glaucoma 
 br 
 J. 
 Ophthalmol 
 Suppl 
 1 
 1–169 doi:10.1136/ 
 bjophthalmol-2021-egsguideline 
 Bonomi L. Marchini G. Marraffa M. Bernardi P. Morbio R. Varotto a. 
 2000 vascular risk factor primary open angle glaucoma Egna-Neumarkt 
 Study ophthalmology 107 7 1287–1293 doi:10.1016/s0161 6420(00)00138-x 
 Chalmers R. L. Begley C. G. Caffery B. 2010 validation 5-item Dry Eye 
 Questionnaire deq-5 discrimination self-assessed severity aqueous tear 
 deﬁcient dry eye diagnosis cont Lens Anterior Eye 33 2 55–60 doi:10.1016/j.clae 
 2009.12.010 
 Chiquet C. Gavard O. Arnould L. Mautuit T. Macgillivray T. J. Bron a. M. et al. 
 2020 retinal vessel phenotype patient primary open-angle glaucoma acta 
 Ophthalmol 98 1 e88–e93 doi:10.1111/aos.14192 
 Choi J. a. Lee S. N. Jung S. H. Won H. H. Yun J. S. 2023 association 
 glaucoma lifestyle incident cardiovascular disease longitudinal prospective 
 study UK Biobank Sci Rep. 13 1 2712 doi:10.1038/s41598 023 29613-w 
 Chrysostomou V. Rezania F. Trounce I. a. Crowston J. G. 2013 oxidative 
 stress mitochondrial dysfunction glaucoma curr opin pharmacol 13 1 
 12–15 doi:10.1016/j.coph.2012.09.008 
 chu-tan J. a. Kirkby M. Natoli R. 2022 run save sight effect 
 exercise retinal health function clin exp ophthalmol 50 1 74–90 doi:10 
 1111/ceo.14023 
 Craig C. L. Marshall A. L. Sjöström M. Bauman A. E. Booth M. L. Ainsworth B. 
 E. et al. 2003 international physical activity questionnaire 12-country reliability 
 validity med Sci sport Exerc 35 8) 1381–1395 doi:10.1249/01.mss.0000078924 
 61453.fb 
 Dascalu A. M. Stana D. Nicolae V. A. Cirstoveanu C. Vancea G. Serban D. et al. 
 2021 association vascular comorbidity glaucoma progression four- 
 year observational study exp ther med 21 3 283 doi:10.3892/etm.2021.9714 
 Fhima J. Eijgen J. V. Stalmans I. Men Y. Freiman M. Behar J. a. 2023 
 pvbm Python vasculature biomarker toolbox base retinal blood vessel 
 segmentation computer vision eccv 2022 workshop editor L. Karlinsky 
 T. Michaeli K. Nishino Cham Springer Nature Switzerland 296–312 Lecture 
 Notes Computer Science 
 Flammer J. Konieczka K. 2017 discovery flammer syndrome 
 historical personal perspective epma j. 8 2 75–97 doi:10.1007/s13167 017- 
 0090-x 
 Flammer J. Orgül S. costa V. P. Orzalesi N. Krieglstein G. K. Serra L. M. et al. 
 2002 impact ocular blood ﬂow glaucoma prog retin eye Res 21 4 
 359–393 doi:10.1016/s1350 9462(02)00008 3 
 Green D. J. Hopman M. T. E. Padilla J. Laughlin M. H. Thijssen D. H. J. 
 2017 vascular adaptation exercise human role hemodynamic stimulus 
 Physiol rev. 97 2 495–528 doi:10.1152/physrev.00014.2016 
 Green D. J. Smith K. J. 2018 effect exercise vascular function structure 
 health human cold Spring Harb perspect med 8 4 a029819 doi:10.1101/ 
 cshperspect.a029819 
 Guarnieri a. Carnero E. Bleau a. M. alfonso-bartolozzi B. Moreno- 
 Montañés J. 2020 relationship osdi questionnaire ocular surface 
 change glaucomatous patient int ophthalmol 40 3 741–751 doi:10.1007/ 
 s10792 019 01236-z 
 Gugleta K. Kochkorov A. Waldmann N. Polunina a. Katamay R. Flammer J. 
 et al. 2012 dynamic retinal vessel response ﬂicker light glaucoma patient 
 ocular hypertensive Graefes Arch clin exp ophthalmol 250 4 589–594 doi:10 
 1007/s00417 011 1842 2 
 Hanssen H. streese L. Vilser W. 2022 retinal vessel diameter function 
 cardiovascular risk disease prog retin eye Res 91 101095 doi:10.1016/j 
 preteyeres.2022.101095 
 Heiss C. rodriguez-mateos a. bapir M. Skene S. S. sie H. Kelm M. 2023 
 flow-mediated dilation reference value evaluation endothelial function 
 cardiovascular health Cardiovasc res 119 1 283–293 doi:10.1093/cvr/cvac095 
 Jonas J. B. Aung T. Bourne R. R. Bron a. M. Ritch R. Panda-Jonas S. 2017 
 Glaucoma lancet 390 10108 2183–2193 doi:10.1016/s0140 6736(17)31469 1 
 Kaminsky L. A. Arena R. Beckie T. M. brubaker P. H. Church T. S. Forman D. 
 E. et al. 2013 importance cardiorespiratory ﬁtness United States 
 need national registry policy statement American Heart Association 
 circulation 127 5 652–662 doi:10.1161/cir.0b013e31827ee100 
 Karakucuk Y. Okudan N. Bozkurt B. Belviranlı M. Sezer T. Gorçuyeva S. 
 2020 quantitative assessment effect acute anaerobic exercise macular 
 perfusion swept-source optical coherence tomography angiography young 
 football player int ophthalmol 40 6 1377–1386 doi:10.1007/s10792 020 01303-w 
 Koller a. Toth P. 2012 contribution ﬂow-dependent vasomotor 
 mechanism autoregulation cerebral blood ﬂow J. Vasc res 49 5 
 375–389 doi:10.1159/000338747 
 Kreft D. Doblhammer G. Guthoff R. F. Frech S. 2019 prevalence incidence 
 risk factor primary open-angle glaucoma cohort study base longitudinal 
 datum german public health insurance bmc Public Health 19 1 851 doi:10 
 1186/s12889 019 6935 6 
 Kuntz J. L. Young D. R. Saelens B. E. Frank L. D. Meenan R. T. Dickerson J. F. 
 et al. 2021 validity exercise vital sign tool assess physical activity J. Prev 
 Med 60 6 866–872 doi:10.1016/j.amepre.2021.01.012 
 Kwon J. Lee J. Choi J. Jeong D. Kook M. S. 2017 association 
 nocturnal blood pressure dip optic disc hemorrhage patient normal- 
 tension glaucoma J. Ophthalmol 176 87–101 doi:10.1016/j.ajo.2017.01.002 
 Lambuk L. Mohd Lazaldin M. a. Ahmad S. Iezhitsa I. Agarwal R. Uskoković V. 
 et al. 2022 brain-derived neurotrophic factor-mediated neuroprotection glaucoma 
 review current state art Pharmacol 13 875662 doi:10.3389/fphar 
 2022.875662 
 Lenth R. V. 2001 practical guideline effective sample size determination 
 statistician 55 3 187–193 doi:10.1198/000313001317098149 
 Lin H. C. Chien C. W. Hu C. C. Ho J. D. 2010 comparison comorbid 
 condition open-angle glaucoma patient control cohort case-control 
 study ophthalmology 117 11 2088–2095 doi:10.1016/j.ophtha.2010.03.003 
 Luk T. H. Dai Y. L. siu C. W. Yiu K. H. Chan H. T. Lee S. W. L. et al. 2012 
 effect exercise training vascular endothelial function patient stable 
 coronary artery disease randomized control trial eur J. Prev cardiol 19 4 
 830–839 doi:10.1177/1741826711415679 
 Mangione C. M. Lee P. P. Gutierrez P. R. Spritzer K. Berry S. Hays R. D. et al. 
 2001 development 25-item national eye Institute visual function questionnaire 
 Arch Ophthalmol 119 7 1050–1058 doi:10.1001/archopht.119.7.1050 
 Melgarejo J. D. Eijgen J. V. Wei D. Maestre G. E. al-aswad L. a. Liao C. T. et al. 
 2023 effect 24-h blood pressure dysregulation reduce ocular perfusion 
 pressure open-angle glaucoma progression J. Hypertens 41 11 1785–1792 doi:10 
 1097/hjh.0000000000003537 
 Moncada S. Higgs a. 1993 l-arginine-nitric oxide pathway N. Engl 
 J. Med 329 27 2002–2012 doi:10.1056/nejm199312303292706 
 Moriguchi J. Itoh H. Harada S. Takeda K. Hatta T. Nakata T. et al. 2005 low 
 frequency regular exercise improve ﬂow-mediated dilatation subject mild 
 hypertension hyperten res 28 4 315–321 doi:10.1291/hypres.28.315 
 Nayyar S. Kumar S. Rehman O. Ichhpujani P. Singla E. 2022 impact 
 moderate severe primary open-angle glaucoma quality life 
 activity limitation indian J. Ophthalmol 70 2 552–557 doi:10.4103/ijo ijo 
 1687_21 
 Nita M. grzybowski a. 2016 role reactive oxygen specie 
 oxidative stress pathomechanism age-related ocular disease 
 pathology anterior posterior eye segment adult oxidative Med cell 
 Longev 2016 3164734 doi:10.1155/2016/3164734 
 Palmer R. M. Ashton D. S. Moncada S. 1988 vascular endothelial cell 
 synthesize nitric oxide l-arginine nature 333 6174 664–666 doi:10.1038/ 
 333664a0 
 Pelliccia a. Sharma S. Gati S. Bäck M. Börjesson M. Caselli S. et al. 2020 
 2020 ESC Guidelines sport cardiology exercise patient cardiovascular 
 disease eur heart j;42(1):17–96 doi:10.1093/eurheartj/ehaa605 
 Peters D. Bengtsson B. Heijl a. 2014 factor associate lifetime risk 
 open-angle glaucoma blindness acta Ophthalmol 92 5 421–425 doi:10.1111/aos 
 12203 
 Pinazo-Durán M. D. Zanón-Moreno V. Gallego-Pinazo R. garcía-medina 
 J. J. 2015 oxidative stress mitochondrial failure pathogenesis glaucoma 
 neurodegeneration prog brain res 220 127–153 doi:10.1016/bs.pbr.2015.06.001 
 Quigley H. a. 2011 glaucoma lancet 377 9774 1367–1377 doi:10.1016/s0140- 
 6736(10)61423 7 
 Ramos J. S. Dalleck L. C. Tjonna A. E. Beetham K. S. Coombes J. S. 2015 
 impact high-intensity interval training versus moderate-intensity continuous 
 training vascular function systematic review meta-analysis sport Med 45 5 
 679–692 doi:10.1007/s40279 015 0321-z 
 ras R. T. Streppel M. T. draijer R. Zock P. L. 2013 flow-mediated dilation 
 cardiovascular risk prediction systematic review meta-analysis int 
 J. Cardiol 168 1 344–351 doi:10.1016/j.ijcard.2012.09.047 
 Frontiers Physiology 
 frontiersin.org 
 12 
 Van Eijgen et al. 
 10.3389/fphys.2024.1349313 
 Saccà S. C. Pascotto a. Camicione P. Capris P. Izzotti a. 2005 oxidative 
 dna damage human trabecular meshwork clinical correlation patient 
 primary open-angle glaucoma arch ophthalmol 123 4 458–463 doi:10.1001/ 
 archopht.123.4.458 
 Seidelmann S. B. Claggett B. Bravo P. E. Gupta a. Farhad H. Klein B. E. et al. 
 2016 retinal vessel caliber predict long-term cardiovascular outcome 
 atherosclerosis risk community study circulation 134 18 1328–1338 doi:10 
 1161/circulationaha.116.023425 
 Streese L. Deiseroth a. Schäfer J. schmidt-trucksäss a. Hanssen H. 2018 
 Exercise arterial crosstalk-modulation inﬂammation aging population 
 examin age study physiol 9 116 doi:10.3389/fphys.2018.00116 
 streese L. Khan A. W. Deiseroth a. Hussain S. Suades R. Tiaden a. et al. 
 2020b high-intensity interval training modulate retinal microvascular phenotype 
 dna methylation p66shc gene randomized control trial examin age 
 eur heart J. 41 15 1514–1519 doi:10.1093/eurheartj/ehz196 
 Streese L. Kotliar K. deiseroth a. Infanger D. Gugleta K. Schmaderer C. et al. 
 2020a retinal endothelial function cardiovascular risk patient randomized 
 controlled exercise trial scand J. Med Sci sport 30 2 272–280 doi:10.1111/sm 
 13560 
 Streese L. Lona G. Wagner J. Knaier R. burri a. Nève G. et al. 2021 
 normative datum standard operating procedure static dynamic retinal 
 vessel analysis biomarker cardiovascular risk sci Rep. 11 1 14136 doi:10.1038/ 
 s41598 021 93617 7 
 Susanna R. Jr De Moraes C. G. Ciofﬁ G. a. Ritch R. 2015 people 
 blind glaucoma Transl vis Sci technol 4 2 1 doi:10.1167/tvst.4.2.1 
 Swain D. P. Leutholtz B. C. 1997 heart rate reserve equivalent 
 vo2 reserve vo2max med Sci sport Exerc 29 3 410–414 doi:10.1097/ 
 00005768 199703000 00018 
 Talaat K. Fathi O. T. Alamoudi S. M. Alzahrani M. G. Mukhtar R. M. Khan 
 M. a. 2021 type glaucoma associate comorbiditie patient king 
 abdulaziz medical city jeddah cureus 13 6 15574 doi:10.7759/cureus.15574 
 Tham Y. C. Li X. Wong T. Y. Quigley H. a. Aung T. Cheng C. Y. 2014 
 global prevalence glaucoma projection glaucoma burden 2040 
 systematic review meta-analysis ophthalmology 121 11 2081–2090 doi:10.1016/ 
 j.ophtha.2014.05.013 
 Thijssen D. H. J. Black M. a. Pyke K. E. Padilla J. Atkinson G. Harris R. A. et al. 
 2011 assessment ﬂow-mediated dilation human methodological 
 physiological guideline J. Physiol Heart Circ physiol 300 1 2–12 doi:10 
 1152/ajpheart.00471.2010 
 Tjønna A. E. Lee S. J. Rognmo Ø. Stølen T. O. Bye a. Haram P. M. et al. 2008 
 aerobic interval training versus continuous moderate exercise treatment 
 metabolic syndrome pilot study circulation 118 4 346–354 doi:10.1161/ 
 circulationaha.108.772822 
 Topouzis F. Wilson M. R. Harris a. Anastasopoulos E. Yu F. Mavroudis L. et al. 
 2007 prevalence open-angle glaucoma Greece thessaloniki eye study 
 J. Ophthalmol 144 4 511–519 doi:10.1016/j.ajo.2007.06.029 
 Valenzuela P. L. Ruilope L. M. Santos-Lozano a. Wilhelm M. Kränkel N. Fiuza- 
 Luces C. et al. 2023 exercise beneﬁts cardiovascular disease mechanism 
 clinical implementation eur heart J. 44 21 1874–1889 doi:10.1093/eurheartj/ 
 ehad170 
 Van Bortel L. M. Laurent S. Boutouyrie P. Chowienczyk P. Cruickshank J. K. De 
 Backer T. et al. 2012 expert consensus document measurement aortic 
 stiffness daily practice carotid-femoral pulse wave velocity J. Hypertens 30 3 
 445–448 doi:10.1097/hjh.0b013e32834fa8b0 
 Van Eijgen J. Melgarejo J. D. Van Laeken J. Van Der Pluijm C. Matheussen H. 
 Verhaegen M. et al. 2023 relevance arterial blood pressure management 
 glaucoma progression systematic review J. Hypertens hpad111 
 Venkataraman S. T. Flanagan J. G. Hudson C. 2010 vascular reactivity 
 optic nerve head retinal blood vessel glaucoma review microcirculation 17 
 7 568–581 doi:10.1111/j.1549 8719.2010.00045.x 
 Vera J. Jiménez R. Redondo B. Cárdenas D. McKay B. R. garcía-ramos a. 
 2019 acute intraocular pressure response high-intensity interval-training 
 protocol man woman J. Sports Sci 37 7 803–809 doi:10.1080/02640414 
 2018.1527674 
 Vlachopoulos C. Aznaouridis K. Stefanadis C. 2010 prediction 
 cardiovascular event all-cause mortality arterial stiffness systematic 
 review meta-analysis J. coll cardiol 55 13 1318–1327 doi:10.1016/j 
 jacc.2009.10.061 
 Wändell P. Carlsson A. C. Ljunggren G. 2022 systemic disease 
 association open-angle glaucoma population Stockholm Int ophthalmol 
 42 5 1481–1489 doi:10.1007/s10792 021 02137-w 
 Wang X. Jiang C. Ko T. Kong X. Yu X. Min W. et al. 2015 correlation 
 optic disc perfusion glaucomatous severity patient open-angle 
 glaucoma optical coherence tomography angiography study Graefes Arch Clin 
 Exp ophthalmol 253 9 1557–1564 doi:10.1007/s00417 015 3095-y 
 Weston K. S. Wisløff U. Coombes J. S. 2014 high-intensity interval training 
 patient lifestyle-induced cardiometabolic disease systematic review meta- 
 analysis br J. Sports Med 48 16 1227–1234 doi:10.1136/bjsports-2013 092576 
 Whyte L. J. Ferguson C. Wilson J. Scott R. a. Gill J. M. R. 2013 effect single 
 bout high-intensity exercise metabolic health biomarker overweight/obese 
 sedentary man metabolism 62 2 212–219 doi:10.1016/j.metabol.2012.07.019 
 Wisløff U. Ellingsen Ø. Kemi O. J. 2009 high-intensity interval training 
 maximize cardiac beneﬁts exercise training Exerc Sport Sci Rev. 37 3 139–146 
 doi:10.1097/jes.0b013e3181aa65fc 
 Zhou L. Li Y. Yue B. Y. 1999 oxidative stress affect cytoskeletal structure 
 cell-matrix interaction cell ocular tissue trabecular meshwork 
 J. Cell physiol 180 2 182–189 doi:10.1002/(sici)1097 4652(199908)180:2<182 
 aid-jcp6>3.0.co;2-x 
 Zhu M. M. lai J. S. M. Choy B. N. K. Shum J. W. H. Lo A. C. Y. Ng A. L. K. et al. 
 2018 physical exercise glaucoma review role physical exercise 
 intraocular pressure control ocular blood ﬂow regulation neuroprotection glaucoma- 
 related mental health Acta Ophthalmol 96 6 e676–e691 doi:10.1111/aos.13661 
 Frontiers Physiology 
 frontiersin.org 
 13 
 Van Eijgen et al. 
 10.3389/fphys.2024.1349313 
